Drugmakers in Japan struggle to keep pace in COVID-19 medicine race
No applications for drugs specifically tailored to COVID-19 have been filed yet, as domestic pharmaceutical companies have not invested heavily enough in biomedicine.
U.K. finds Japanese arthritis drug is effective for COVID-19 treatment
The British government said Thursday that two arthritis drugs, including one developed in Japan, are effective in treating patients with COVID-19. In clinical trials funded by the government, the risk of death dropped by 24% for COVID-19 patients treated with the two drugs — tocilizumab ...
Chugai stock surges 60% to rival Sony's value on hopes for virus treatment
Chugai Pharmaceutical is now Japan's biggest drug company by market value after overtaking Daiichi Sankyo and Takeda Pharmaceutical.
Roche said to have decided against bidding for rest of Chugai
Roche Holding AG decided against bidding for the almost 40 percent of drugmaker Chugai Pharmaceutical Co. that it doesn't already own and is instead focused on its $8.3 billion acquisition of InterMune Inc., according to a person familiar with the matter. As it worked on ...
